Lilly’s Humalog Junior KwikPen offers 0.5 unit dose increments in prefilled, disposable device – a win for highly insulin sensitive users
Diabetes Drug News
Diabetes Drugs are responsible for helping to decrease blood sugar levels so that you can try to stay in a healthier range and help avoid serious complications.
Metformin Insulin SGLT-2 GLP-1 DPP-4 Combo drugs Sulfonylureas TZDs
38 readers recommended
The FDA decision on Novo Nordisk’s basal insulin is based on positive safety and efficacy data of Tresiba versus other basal insulins
34 readers recommended
Amalgam Rx receives FDA clearance for basal insulin dosing app, iSage Rx; available with a prescription to adjust Lantus, Levemir, Toujeo, Tresiba, and Basaglar
37 readers recommended
How to get cheaper drugs, find discount programs, get free care in clinical trials, and more
44 readers recommended
Novo Nordisk’s once-weekly injectable GLP-1 for type 2 diabetes recommended for approval, given strong A1c reduction and weight loss
44 readers recommended
Includes insulin dose advisor software; plus, a new Novo Nordisk connected Echo insulin pen to debut in Europe later this year
39 readers recommended
An FDA advisory panel voted 17-2 to expand the drug label for type 2 diabetes drug Victoza to reflect a 13% reduction in overall heart risk and 22% reduction in heart-...
27 readers recommended
How I avoid highs, prevent lows, and stop blood sugar frustration during exercise
45 readers recommended
Easy-to-use Bydureon pen cuts down on the hassle of once-weekly injections by offering convenient mixing, a hidden needle, and more
53 readers recommended
A basal insulin and GLP-1 agonist combo becomes available in the US and receives approval in Europe
41 readers recommended
Information about diabetes supplies for those hit by the storms and for those who can help them
33 readers recommended
First trial next month, launch expected in 2-3 years; Dexcom CGM included; a big commitment to diabetes tech innovation from an insulin company
40 readers recommended
Seeking participants with type 2 diabetes to investigate the effects of semaglutide on heart health
39 readers recommended
Full results of DEVOTE study presented at ADA 2017 show that basal insulin Tresiba reduces risk of severe hypoglycemia by 40% (by 53% overnight), in addition to being...
36 readers recommended
FDA Approves New GLP-1 Label on Victoza to show that the medicine makes hearts healthier!
30 readers recommended
What’s new in smart pens and caps for capturing injection doses? Plus, two cool new health apps with built-in artificial intelligence
41 readers recommended
Cash-pay strips with good accuracy and co-pay programs to save money
33 readers recommended
CANVAS study presented at ADA 2017 highlights heart and kidney protection for type 2 diabetes drug Invokana, and questions persist over an increased risk of amputations
46 readers recommended
A recent trial comparing once-weekly GLP-1 agonists semaglutide and Trulicity found improved A1c and double the weight loss with semaglutide
42 readers recommended
Novo Nordisk’s newest insulin receives EMA approval; expected to launch in the first half of 2017